Where do Oruka Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Oruka Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-27.3%-2.6pp	-24.7%+13.8pp	-38.5%—	——	-85.3%-17.7pp
Return on assets	-26.4%-2.5pp	-23.8%+10.7pp	-34.6%+46.2pp	-80.7%+1.8pp	-82.5%-17.2pp
Return on invested capital	-37%-4.4pp	-32.6%+17.5pp	-50.1%—	——	——
Liquidity
Current ratio	23.8×+1.4×	22.4×+5.4×	16.9×-10.5×	27.4×-2.6×	30×+1.1×
Quick ratio	23.8×+1.4×	22.4×+5.4×	16.9×-10.5×	27.4×-2.6×	30×+1.1×
Cash ratio	3×-0.1×	3.1×-1.3×	4.4×-1.0×	5.4×-1.7×	7.1×+2.4×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$2.43B+65.6%	$1.47B+57.7%	$930.43M+111%	$440.3M+14.6%	$384.14M-43.4%
Enterprise value	$2.38B+67.5%	$1.42B+69.1%	$841.09M+123%	$377.23M+25.1%	$301.51M-51.2%
Price / book	5×+1.9×	3.1×+1.2×	1.9×+0.6×	1.3×+0.2×	1.1×-0.7×
Free cash flow yield	-3.8%+2.3pp	-6%+7.3pp	-13.3%+18.8pp	-32.1%—	——
Earnings yield	-4.8%+2.4pp	-7.2%+10.0pp	-17.2%+18.7pp	-35.9%+4.6pp	-40.5%-19.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Oruka Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Oruka Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.